Skrining kolorektalnog karcinoma u Srbiji – od prevencije do ranog otkrivanja

IV Međunarodni kongres UZPS Empatija zdravstvenih profesionalaca – put do razumevanja drugih, (str. 243-251)

AUTOR(I) / AUTHOR(S):Aleksandra CVETKOVIĆ, Ana MILJKOVIĆ

Download Full Pdf   

DOI: https://doi.org/10.46793/IVUZPS.243C

SAŽETAK / ABSTRACT:

Maligne bolesti predstavljaju sve veći javno-zdravstveni problem i značajno opterećuju društvo. Odmah posle kardiovaskularnih bolesti, drugi vodeći uzrok obolevanja su maligni tumori. U Srbiji je kolorektalni karcinom drugi najčešći kod žena (iza raka dojke) i muškaraca (iza raka pluća). Poznati su brojni faktori koji povećavaju ili smanjuju rizik obolevanja.

Prevencija je usmerena na smanjenje broja obolelih, poboljšanje kvaliteta života i smanjenje troškova lečenja. Skrining podrazumeva primenu testa u presimptomatskoj fazi bolesti radi ranog otkrivanja ili identifikacije prekursora invazivne bolesti. Sprovodi se u asimptomatskoj populaciji prosečnog rizika radi otkrivanja ranih stadijuma i mogućnosti pravovremene terapije.

KLJUČNE REČI / KEYWORDS:

kolorektalni karcinom, skrining, rano otkrivanje, javnozdravstveni program, faktori rizika, primarna zdravstvena zaštita

LITERATURA / REFERENCES:

  1. American Cancer Society. Colorectal cancer: causes, risk factors and prevention topics [internet]. Dostupno na: http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-risk-factors
  2. Dugandžija T, Kukić B. Etiologija, distribucija i prevencija raka debelog creva. Novi Sad: Zdravlje u životu; 2014.
  3. Miladinov-Mikov M. Colorectal cancer epidemiology. Arch Oncol. 2010;18(1):11.
  4. Levin T, Jamieson L, Burley D, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33:101–10.
  5. Binefa G, Rodriguez-Moranta F, Teule A, Medina-Hayas M. Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol. 2014;20(22):6786–808.
  6. Krivokapić ZV. Karcinom rektuma. Beograd: 2012.
  7. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002;31(4):925–43.
  8. Bosetti C, Bravi F, Negri E, La Vecchia C. Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update. 2009;15:489–98.
  9. Kim JY, Kwon O. Garlic intake and cancer risk: an analysis using the Food and Drug Administration’s evidence-based review system for the scientific evaluation of health claims. Am J Clin Nutr. 2009;89:257–64.
  10. Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res. 2012.
  11. Binefa G, Rodriguez-Moranta F, Teule A, Medina-Hayas M. Colorectal cancer: from prevention to personalized medicine. Bethesda: National Center for Biotechnology Information; 2014.
  12. Krdžić ID. Parametri radikalnosti kod laparoskopske i otvorene hirurgije karcinoma kolona i rektuma [doktorska disertacija]. Beograd: Medicinski fakultet Univerziteta u Beogradu; 2018.
  13. Bretthauer M. Colorectal cancer screening. J Intern Med. 2011;270(2):87–98.
  14. Ministarstvo zdravlja Republike Srbije – Republička stručna komisija za izradu i implementaciju vodiča dobre kliničke prakse. Nacionalni vodič dobre kliničke prakse za dijagnostiku i lečenje raka kolona i debelog creva. Beograd: Ministarstvo zdravlja Republike Srbije; 2013.
  15. Koo HJ, Leong WR, Ching J, Yeoh KhG, Wu DCh, Murdani A, et al. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc. 2012;76:126–35.
  16. Institut za javno zdravlje Srbije „Dr Milan Jovanović Batut“. Kancelarija za skrining raka. Beograd: Institut „Batut“; 2020.
  17. Sung JJY, Lau JYW, Goh KL, Leung WK; Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6(11):871–6.
  18. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103(9):714–36.
  19. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–73.